Impact of chronic kidney disease on long‐term clinical outcomes of everolimus‐eluting stent implantation: A subanalysis of the Tokyo‐MD PCI registry

The aim of the study was to investigate the impact of chronic kidney disease (CKD) on the 5‐year clinical outcomes of everolimus‐eluting stent (EES) implantation.

• Publication year

  2019

• Venue

  Catheterization and cardiovascular interventions

• Publication date

  2019-02-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ccd.28070PMID 30714680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guideline

  2020cited by this paper
• Cardiorenal Syndrome

  2020cited by this paper
• Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study

  2018cited by this paper
• Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)

  2018influential reference
• Incidence and predictors of early and late target lesion revascularization after everolimus‐eluting stent implantation in unselected patients in japan

  2017influential reference
• The Risk of Major Hemorrhage with CKD.

  2016cited by this paper
• Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model.

  2015cited by this paper
• Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice).

  2015cited by this paper
• Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry).

  2013cited by this paper
• Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline

  2013cited by this paper
• Chronic kidney disease is associated with neovascularization and intraplaque hemorrhage in coronary atherosclerosis in elders: results from the Hisayama Study.

  2013cited by this paper
• Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes.

  2012cited by this paper
• Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents: A Prospective Cohort Study

  2012cited by this paper
• Comparison of everolimus-eluting stent with paclitaxel-eluting stent in long chronic total occlusions.

  2011cited by this paper
• Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization.

  2011cited by this paper
• Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database.

  2011cited by this paper
• Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial.

  2011cited by this paper
• Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium

  2011cited by this paper
• Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.

  2010cited by this paper
• Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

  2009cited by this paper
• Proteinuria and stroke: a meta-analysis of cohort studies.

  2009cited by this paper
• The Adverse Long-Term Impact of Renal Impairment in Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stent Era

  2009cited by this paper
• In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.

  2009cited by this paper
• Coronary calcification in patients with chronic kidney disease and coronary artery disease.

  2009cited by this paper
• Association of serum phosphate with vascular and valvular calcification in moderate CKD.

  2009cited by this paper
• Cardiorenal syndrome.

  2008cited by this paper
• Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.

  2008cited by this paper
• Endothelial cell recovery between comparator polymer-based drug-eluting stents.

  2008cited by this paper
• Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions

  2007cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.

  2004cited by this paper
• Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

  2003cited by this paper
• The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions.

  2002cited by this paper
• Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency.

  2002cited by this paper
• Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

  2000cited by this paper
• Epidemiology of cardiovascular disease in chronic renal disease

  2000cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Epidemiology of cardiovascular disease in chronic renal disease.

  1998cited by this paper

• One‐year clinical outcomes in patients with chronic kidney disease treated with COMBO stents: From the COMBO collaboration

  2020influential citation